⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19708778 | 0.93 | — | — | |
| SCHEMBL21627160 | 0.73 | KDM4E (0.31) | — | |
| SCHEMBL11280612 | 0.69 | — | — | |
| SCHEMBL19243853 | 0.69 | — | — | |
| SCHEMBL22268222 | 0.68 | — | — | |
| SCHEMBL22268216 | 0.68 | — | — | |
| SCHEMBL783007 | 0.67 | — | — | |
| SCHEMBL329516 | 0.67 | BRD4 (0.48) | — | |
| SCHEMBL21105659 | 0.64 | — | — | |
| SCHEMBL13959889 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10640511-B2 | Hepatitis B antiviral agents | Enant Pharmaceuticals, Inc. (US) | 2020-05-05 | — | — | US | disclosed |
| US-20190119288-A1 | HEPATITIS B ANTIVIRAL AGENTS | ENANTA PHARM INC (US) | 2019-04-25 | — | — | US | disclosed |